Trials / Sponsors / Remix Therapeutics
Remix Therapeutics
Industry · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of REM-422 in Patients With AML or Higher Risk MDS Myelodysplastic Syndromes, Higher Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia | Phase 1 | 2024-04-26 |
| Recruiting | Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma | Phase 1 / Phase 2 | 2023-12-20 |